Literature DB >> 14752815

Structural biology of hepatitis C virus.

François Penin1, Jean Dubuisson, Felix A Rey, Darius Moradpour, Jean-Michel Pawlotsky.   

Abstract

Hepatitis C virus (HCV) causes acute and chronic liver disease in humans, including chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Studies of this virus have been hampered by the lack of a productive cell culture system; most information thus has been obtained from analysis of the HCV genome, heterologous expression systems, in vitro and in vivo models, and structural analyses. Structural analyses of HCV components provide an essential framework for understanding of the molecular mechanisms of HCV polyprotein processing, RNA replication, and virion assembly and may contribute to a better understanding of the pathogenesis of hepatitis C. Moreover, these analyses should allow the identification of novel targets for antiviral intervention and development of new strategies to prevent and combat viral hepatitis. This article reviews the current knowledge of HCV structural biology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14752815     DOI: 10.1002/hep.20032

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  197 in total

1.  Poly(C)-binding protein 2 interacts with sequences required for viral replication in the hepatitis C virus (HCV) 5' untranslated region and directs HCV RNA replication through circularizing the viral genome.

Authors:  Linya Wang; King-Song Jeng; Michael M C Lai
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

Review 2.  Involvement of autophagy in alcoholic liver injury and hepatitis C pathogenesis.

Authors:  Natalia A Osna; Paul G Thomes; Terrence M Donohue
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

3.  CD59 incorporation protects hepatitis C virus against complement-mediated destruction.

Authors:  Tohti Amet; Marwan Ghabril; Naga Chalasani; Daniel Byrd; Ningjie Hu; Ayslinn Grantham; Ziqing Liu; Xuebin Qin; Johnny J He; Qigui Yu
Journal:  Hepatology       Date:  2011-12-16       Impact factor: 17.425

Review 4.  Hepatitis C virus: assembly and release of virus particles.

Authors:  Daniel M Jones; John McLauchlan
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

5.  Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase.

Authors:  Shuanghu Liu; Cassie A Nelson; Li Xiao; Ling Lu; Punit P Seth; Darrell R Davis; Curt H Hagedorn
Journal:  Antiviral Res       Date:  2010-11-12       Impact factor: 5.970

6.  In vitro resistance profile of the hepatitis C virus NS3/4A protease inhibitor TMC435.

Authors:  Oliver Lenz; Thierry Verbinnen; Tse-I Lin; Leen Vijgen; Maxwell D Cummings; Jimmy Lindberg; Jan Martin Berke; Pascale Dehertogh; Els Fransen; Annick Scholliers; Katrien Vermeiren; Tania Ivens; Pierre Raboisson; Michael Edlund; Susan Storm; Lotta Vrang; Herman de Kock; Gregory C Fanning; Kenneth A Simmen
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

7.  Hepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular IkappaB kinase.

Authors:  Soo-Ho Choi; Kyu-Jin Park; Byung-Yoon Ahn; Guhung Jung; Michael M C Lai; Soon B Hwang
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 8.  Epistatic connectivity among HCV genomic sites as a genetic marker of interferon resistance.

Authors:  James Lara; Yury Khudyakov
Journal:  Antivir Ther       Date:  2012-12-07

9.  Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation.

Authors:  Urtzi Garaigorta; Francis V Chisari
Journal:  Cell Host Microbe       Date:  2009-12-17       Impact factor: 21.023

10.  Genetic analysis of the carboxy-terminal region of the hepatitis C virus core protein.

Authors:  Martina Kopp; Catherine L Murray; Christopher T Jones; Charles M Rice
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.